Recombinant Host Cells With Optimized TyrH for Higher L-DOPA Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing L-DOPA, dopamine, and (S)-norcoclaurine in heterologous host cells are inefficient, and there is a need for improved production yields.
Innovation Solution
Utilizing recombinant microbial host cells with enhanced L-tyrosine hydroxylases (TyrH) and a biosynthetic metabolic pathway that includes additional enzymes to convert L-tyrosine into L-DOPA, dopamine, and (S)-norcoclaurine, achieving higher production yields compared to previous methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing methods are used for producing L-DOPA, dopamine, and (S)-norcoclaurine in heterologous host cells, then the production process is simpler, but the production yield is insufficient
Solution Approach 1:
The biosynthetic pathway is segmented into distinct functional modules: L-tyrosine hydroxylase for L-DOPA production, aromatic L-amino acid decarboxylase for dopamine production, and (S)-norcoclaurine synthase for (S)-norcoclaurine production. Each module can be independently optimized and expressed in heterologous host cells, allowing systematic improvement of production yield while maintaining manageable complexity through modular organization
Solution Approach 2:
The invention optimizes multiple parameters including enzyme expression levels, cofactor availability (tetrahydrobiopterin for TyrH, pyridoxal phosphate for DC), pH, temperature, and induction conditions to maximize production yield. Specific embodiments use inducible promoters and optimized cultivation conditions to achieve 50-200% higher yields compared to existing methods
2Productivity
If L-tyrosine hydroxylase is used to convert L-tyrosine into L-DOPA, then the production of L-DOPA is achieved, but the production yield is insufficient compared to improved TyrH variants
Solution Approach 1:
The invention uses copies of optimized L-tyrosine hydroxylase genes (such as TyrH from Rattus norvegicus or optimized plant TyrH variants) introduced into heterologous host cells. Multiple copies or high-expression variants are employed to achieve sufficient catalytic activity and production yield, bypassing the need for complex enzyme engineering in the host system
Solution Approach 2:
The invention introduces intermediary molecules including tetrahydrobiopterin (BH4) as a cofactor for L-tyrosine hydroxylase activity, and uses intermediary metabolic pathways to ensure adequate supply of L-tyrosine substrate. These intermediaries facilitate efficient enzyme function and overcome limitations of heterologous expression
3Adaptability or versatility
If additional enzymes are added to the biosynthetic pathway to produce dopamine and (S)-norcoclaurine, then the product diversity is improved, but the pathway complexity increases
Solution Approach 1:
The recombinant host cell is engineered to perform multiple functions within a single integrated pathway: producing L-DOPA via TyrH, converting L-DOPA to dopamine via DC, and synthesizing (S)-norcoclaurine via NCS using dopamine and 4-hydroxyphenylacetaldehyde as substrates. This multi-functional pathway allows diverse alkaloid production from a single precursor (L-tyrosine) while maintaining coordinated regulation
Solution Approach 2:
The pathway is designed to perform preliminary actions by pre-establishing the L-tyrosine to L-DOPA conversion and dopamine synthesis steps before committing to (S)-norcoclaurine production. This sequential organization allows flexible control where intermediates can be diverted to different products based on demand, managing complexity through staged metabolic commitments
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The recombinant host cells significantly increase the production of L-DOPA, dopamine, and (S)-norcoclaurine, with yields improved by at least 50% to 200% over previous methods, enabling the production of pharmaceutical compounds like Berberine, Papaverine, Morphine, and other benzylisoquinoline alkaloids.
Implementation Method 1
one or more heterologous L-tyrosine hydroxylases (TyrH) converting L-Tyrosine into L-dopa
Implementation Method 2
said pathway comprising one or more heterologous L-tyrosine hydroxylases (TyrH) converting L-Tyrosine into L-dopa
Data Source
AI summary
The present invention relates to a recombinant microbial host cell comprising an operative biosynthetic metabolic pathway capable of producing one or more compounds selected from the group consisting of L-dopa, dopamine, (S)-Norcoclaurine and derivatives thereof; said pathway comprising a heterologous L-tyrosine hydroxylase (TyrH) converting L-Tyrosine into L-dopa capable of increasing the cell production of the Compound compared to a reference L-tyrosine hydroxylase having the sequence set forth in SEQ ID NO: 58.